A Study to Evaluate the Safety and Tolerability of Single and Multiple Ascending Doses of HPN-01 in Healthy Subjects
Clinical trial NCT04481594 · UNKNOWN
Trial details
- NCT number
- NCT04481594
- Sponsor
- Hepanova Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-08
- Primary completion
- 2021-07-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.